Stockreport

Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck's Keytruda [Seeking Alpha]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Padcev, with Merck's ( MRK ) anti-PD-1 therapy Keytruda, succeeded in a Phase 3 pivotal trial for certain patients with muscle-invasive bladder cancer (MIBC). Citing t [Read more]